课题基金 / 基金详情

LUPUS ANTICOAGULANT AND RECURRENT PREGNANCY LOSS

LUPUS ANTICOAGULANT AND RECURRENT PREGNANCY LOSS
狼疮抗凝剂与复发性流产
批准号:
3320406
负责人:
DAVID WARE BRANCH
金额:
$11.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-04-01 至 1990-03-31

项目摘要

项目成果

DAVID WARE BRANCH的其他基金

相似基金

相关文献

中文摘要
翻译
狼疮抗凝剂(LAC)是一种自身抗体,与 复发性早孕流产和中期胎儿死亡, 使用抗凝剂的妇女中80%或更多的妊娠结局为胎儿 浪费。在妊娠中期以后进展、严重或 早期子痫前期和胎儿生长迟缓是常见的。Lac是 通常通过其对磷脂依赖的延长效应来检测 凝血,该抗体已被鉴定为抗磷脂。 LAC的病理生理效应被认为是由于抑制了 在体外观察到的血管前列环素的产生 抗体的存在。我们建议从两个方面研究本地接驳费。第一, 我们将使用以下方法评估LAC的特异性抗原-抗体相互作用 这是我们开发的一种免疫分析方法。我们的初步结果 提示该抗原为磷脂、磷脂酰丝氨酸。 其次,我们将使用前列环素来研究LAC的作用机制 世代试验和小鼠、兔的繁殖模型。动物们 会被各种磷脂制剂主动免疫或 用纯化的人LAC制剂或人或小鼠被动免疫 并对其繁殖性能进行了评价。
英文摘要
Lupus anticoagulant (LAC) is an autoantibody that is associated with recurrent first-trimester abortion and second-trimester fetal death, with 80% or more of pregnancies in women with the anticoagulant ending in fetal wastage. In pregnancies that progress beyond mid-gestation, severe or early preeclampsia and fetal growth retardation are common. LAC is commonly detected by its prolongation-effect on phospholipid-dependent coagulation, and the antibody has been identified as an anti-phospholipid. The pathophysiologic effect of LAC has been attributed to the inhibition of vascular prostacyclin production that has been observed in vitro in the presence of the antibody. We propose to study two aspects of LAC. First, we will evaluate the specific antigen-antibody interactions for LAC using an immunologic assay that we have developed. Our preliminary results suggest that the antigen is the phospholipid, phosphatidylserine. Secondly, we will study the mechanism of LAC using a prostacyclin generation assay and mouse and rabbit models of reproduction. The animals will be actively immunized with various phospholipid preparations or passively immunized with purified human LAC preparations or human or mouse monoclonal LAC, and their reproductive performance evaluated.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Immunologic disease and fetal death.
免疫疾病和胎儿死亡。
DOI: 10.1097/00003081-198706000-00009
发表时间: 1987
期刊: Clinical obstetrics and gynecology
影响因子: 1.5
作者: [Branch,DW]
通讯作者: Branch,DW
A new postpartum syndrome associated with antiphospholipid antibodies.
一种与抗磷脂抗体相关的新产后综合症。
DOI: --
发表时间: 1987
期刊: Obstetrics and gynecology
影响因子: 7.2
作者: [Kochenour,NK, Branch,DW, Rote,NS, Scott,JR]
通讯作者: Scott,JR
Antiphospholipid antibodies and pregnancy: maternal implications.
抗磷脂抗体和怀孕:对母体的影响。
DOI: --
发表时间: 1990
期刊: Seminars in perinatology
影响因子: 3.4
作者: [Branch,DW]
通讯作者: Branch,DW
Association of lupus anticoagulant with antibody against phosphatidylserine.
狼疮抗凝剂与抗磷脂酰丝氨酸抗体的关联。
DOI: 10.1016/0090-1229(87)90173-5
发表时间: 1987
期刊: Clinical immunology and immunopathology
影响因子: --
作者: [Branch,DW, Rote,NS, Dostal,DA, Scott,JR]
通讯作者: Scott,JR
共 6 条
    FETAL STEM CELLS FOR TRANSPLANTATION
    • 批准号:
      2205154
    • 项目类别:
    • 资助金额:
      $28.12万
    • 财政年份:
      1994
    • 负责人:
      DAVID WARE BRANCH
    • 依托单位:
    FETAL STEM CELLS FOR TRANSPLANTATION
    • 批准号:
      2205152
    • 项目类别:
    • 资助金额:
      $23.92万
    • 财政年份:
      1994
    • 负责人:
      DAVID WARE BRANCH
    • 依托单位:
    FETAL STEM CELLS FOR TRANSPLANTATION
    • 批准号:
      2403426
    • 项目类别:
    • 资助金额:
      $26.92万
    • 财政年份:
      1994
    • 负责人:
      DAVID WARE BRANCH
    • 依托单位:
    FETAL STEM CELLS FOR TRANSPLANTATION
    • 批准号:
      2205153
    • 项目类别:
    • 资助金额:
      $28.22万
    • 财政年份:
      1994
    • 负责人:
      DAVID WARE BRANCH
    • 依托单位:
    国内基金
    海外基金
    Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
    • 批准号:
      2022J011295
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2022
    • 负责人:
      王亚伟
    • 依托单位:
    结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究